The recent discovery of a previously unknown fusion gene in acute myeloid leukemia (AML) is shifting current thinking about cancer’s dynamic nature and the drivers of relapse, with implications for customized treatment.
CAR T-cell therapy: exploring new frontiers of treatment
Chimeric antigen receptor T-cell (CAR T-cell) therapy has revolutionized care for certain blood cancers. A new lab at Rady Children’s Health Orange County, formerly called CHOC, hopes to extend the treatment to more patients.
National brain mapping study receives its first ‘magical’ gift from patient with cancer
Ethan Nguyen is the first pediatric patient to become part of an NIH-funded study that began in 2022 and is led by UC Irvine.
Molecular diagnostics enhances personalization of neuro-oncologic care
Learn how molecular diagnostics at Rady Children’s Hospital, Orange gives clinicians deeper insight into brain and spine tumors to help them select the most effective treatment.
Advancing mental health aftercare for pediatric cancer patients
Pathways After Cancer Treatment (PACT), a new bridge clinic at CHOC, helps support the mental health of teen and young adult cancer patients.
Determining the role of regulatory T cells in successful immunotherapy
CHOC researchers seek to study the role of Tregs in whether pediatric leukemia patients treated with CAR T-cell therapy experience a relapse.
